What is HC Wainwright's Estimate for Senseonics Q4 Earnings?

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - Research analysts at HC Wainwright cut their Q4 2025 earnings per share (EPS) estimates for shares of Senseonics in a research report issued to clients and investors on Thursday, August 7th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings of ($0.02) per share for the quarter, down from their prior estimate of ($0.01). HC Wainwright currently has a "Buy" rating and a $1.40 price target on the stock. The consensus estimate for Senseonics' current full-year earnings is ($0.14) per share. HC Wainwright also issued estimates for Senseonics' Q1 2026 earnings at ($0.02) EPS, Q3 2026 earnings at ($0.02) EPS, FY2026 earnings at ($0.06) EPS, FY2027 earnings at ($0.03) EPS, FY2028 earnings at ($0.01) EPS and FY2029 earnings at $0.02 EPS.

A number of other research analysts have also weighed in on SENS. Wall Street Zen raised Senseonics to a "sell" rating in a report on Monday, May 12th. Lake Street Capital raised Senseonics to a "strong-buy" rating in a report on Thursday, July 17th. Finally, TD Cowen initiated coverage on Senseonics in a research note on Tuesday, July 15th. They issued a "buy" rating and a $1.25 price target for the company. One analyst has rated the stock with a sell rating, two have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $1.55.

Senseonics Stock Performance

Shares of SENS stock traded up $0.01 during trading on Monday, reaching $0.47. 3,715,660 shares of the company's stock were exchanged, compared to its average volume of 8,372,748. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. The stock has a market capitalization of $309.71 million, a PE ratio of -3.64 and a beta of 0.88. Senseonics has a twelve month low of $0.25 and a twelve month high of $1.40. The firm's fifty day moving average price is $0.51 and its 200-day moving average price is $0.66.

Institutional Trading of Senseonics

Several institutional investors have recently added to or reduced their stakes in SENS. CTC Alternative Strategies Ltd. bought a new stake in shares of Senseonics during the 1st quarter valued at $31,000. IFP Advisors Inc lifted its position in shares of Senseonics by 120.9% during the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock valued at $31,000 after acquiring an additional 26,000 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Senseonics during the 4th quarter valued at $26,000. Smith Salley Wealth Management bought a new stake in shares of Senseonics during the 1st quarter valued at $36,000. Finally, State of Wyoming bought a new stake in shares of Senseonics during the 1st quarter valued at $40,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.